Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vipoma 2 Somatostatinoma 2 Rectal Neoplasms 2 Insulinoma 2 Glucagonoma 2 Gastrinoma 2 Colorectal Neoplasms 2 Carcinoma, Islet Cell 2 Thymoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Meningioma 1 Drug-Related Side Effects and Adverse Reactions 1 Diarrhea 1 Colonic Neoplasms 1 Breast Neoplasms 1 Anus Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Radiotherapy 2 Psychiatric Rehabilitation 2 Hydroxyurea 2 lutetium Lu 177 dotatate 1 emvododstat 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Proton Therapy 1 Octreotide 1 Observation 1 Mifepristone 1 Ifosfamide 1 Everolimus 1 Chemotherapy, Adjuvant 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Meningioma × Octreotide × Clear all

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡